Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Network Comparison Type Value Type Interaction Map Filtered red network_comparison green
Results: HTML CSV LaTeX
Showing element 1 to 50 of 8289 in total
Network Comparison Type: Divided
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
green\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase d precursor (ec 3.4.17.-) (gp180). [source:swissprot;acc:o75976]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
32\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
UBAC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
28\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
LAMP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 1 precursor (lamp-1) (cd107a antigen). [source:swissprot;acc:p11279]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.47982\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
330\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
3\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDK4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cell division protein kinase 4 (ec 2.7.1.37) (cyclin-dependent kinase 4) (psk-j3). [source:swissprot;acc:p11802]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PSCD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytohesin 1 (sec7 homolog b2-1). [source:swissprot;acc:q15438]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
28\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
4\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDK6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cell division protein kinase 6 (ec 2.7.1.37) (serine/threonine protein kinase plstire). [source:swissprot;acc:q00534]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.47982\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
330\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PSCD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytohesin 2 (arf nucleotide-binding site opener) (arno protein) (arf exchange factor). [source:swissprot;acc:q99418]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
28\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
5\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
LAMP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 2 precursor (lamp-2) (cd107b antigen). [source:swissprot;acc:p13473]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.47982\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
330\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PSCD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
28\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
6\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSBPL6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 6 (osbp-related protein 6) (orp-6). [source:swissprot;acc:q9bzf3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.325\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
240\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PSCD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
28\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
7\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HLX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein hlx1 (homeobox protein hb24). [source:swissprot;acc:q14774]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.49767\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
322\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
OSBPL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 3 (osbp-related protein 3) (orp-3). [source:swissprot;acc:q9h4l5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.325\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
240\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
8\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HBS1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hbs1-like. [source:refseq;acc:nm\_006620]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.49767\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
322\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
OSBPL7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 7 (osbp-related protein 7) (orp-7). [source:swissprot;acc:q9bzf2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.325\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
240\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
9\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPS17\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
44\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
XAB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.45755\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
309\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
10\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATPBD1C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC25A43\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
44\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
11\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
BEST1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bestrophin (vitelliform macular dystrophy protein) (tu15b). [source:swissprot;acc:o76090]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
37.318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30966\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
28.4944\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RINT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.45259\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
232\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
12\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
BEST4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 2. [source:refseq;acc:nm\_153274]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.3475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30933\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
28.5242\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RHOBTB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho-related btb domain-containing protein 2 (deleted in breast cancer 2 gene protein) (p83). [source:swissprot;acc:q9byz6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.45259\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
232\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.9984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30207\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
29.1831\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
UFC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
288.754\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3585\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
212.554\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG4A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
56.6768\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32952\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
75.3531\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
BEST2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 1. [source:refseq;acc:nm\_017682]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.9984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.30207\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
29.1831\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAP1LC3B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
56.7244\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32914\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
75.3948\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
UFC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
255.046\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26035\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
202.362\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
JMJD1C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
thyroid receptor interacting protein 8 (trip-8) (fragment). [source:swissprot;acc:q15652]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
305.472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2355\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
247.246\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAP1LC3A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
56.7252\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32913\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
75.3954\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG4B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
56.7841\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32866\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
75.447\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TMEM132A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
305.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23537\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
247.213\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
GBE1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
245.247\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
JMJD1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
jumonji domain containing 1; zinc finger protein; testis-specific protein a. [source:refseq;acc:nm\_018433]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
305.303\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2352\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
247.169\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRSS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trypsin iii precursor (ec 3.4.21.4) (brain trypsinogen) (mesotrypsinogen) (trypsin iv). [source:swissprot;acc:p35030]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
304.548\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23387\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
246.824\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PYGB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, brain form (ec 2.4.1.1). [source:swissprot;acc:p11216]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
245.247\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRSS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trypsin i precursor (ec 3.4.21.4) (cationic trypsinogen). [source:swissprot;acc:p07477]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
304.359\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23354\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
246.737\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PYGL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, liver form (ec 2.4.1.1). [source:swissprot;acc:p06737]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
185.678\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
245.247\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYO15A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PIGF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidylinositol-glycan biosynthesis, class f protein (pig-f). [source:swissprot;acc:q07326]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21472\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
163\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PYGM\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.678\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32082\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
245.247\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TUSC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
n33 protein. [source:swissprot;acc:q13454]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
198\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.21472\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
163\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
implantation-associated protein. [source:refseq;acc:nm\_032121]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
MRPS17\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
44\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HINT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histidine triad nucleotide-binding protein 1 (adenosine 5'- monophosphoramidase) (protein kinase c inhibitor 1) (protein kinase c- interacting protein 1) (pkci-1). [source:swissprot;acc:p49773]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
188.298\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21355\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
228.509\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PANK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
44\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP27B1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
286.396\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20094\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
238.476\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PANK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
44\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/